North America Breast Reconstruction, By Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others) – Industry Trends and Forecast to 2030.
North America Breast Reconstruction Market Analysis and Size
The rising prevalence and incidence of breast cancer and increased awareness of reconstructive breast surgeries are propelling the breast reconstruction market forward. The rise can be attributed to an increase in the number of breast cancer patients as well as the availability of favourable reimbursement policies. Furthermore, technological advancements and an increase in the number of breast reconstruction procedures are expected to drive market growth.
Data Bridge Market Research analyses that the North America breast reconstruction market which is USD 926.28 million in 2022, is expected to reach USD 1805.42 million by 2030, at a CAGR of 8.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Breast Reconstruction Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 20230
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
|
|
Market Opportunities
|
|
Market Definition
Breast reconstruction is a surgery that reshapes the breasts. Breast implants are used to contour the breasts in conjunction with silicone devices filled with silicone gel or salt water (saline). Breast implant surgery is a difficult procedure. Breast restoration treatments are currently available, including nipple repair and a regenerative medicine approach using 3D Printed Tissue Scaffolds. Treatments for nipple reconstruction have progressed from a local skin flagship surgical method to current tissue engineering approaches.
North America Breast Reconstruction Market Dynamics
Drivers
- Growing number of breast reconstruction procedures
The increasing number of breast reconstruction procedures is expected to fuel market growth. The National Center for Biotechnology Information reports that the rate of post-mastectomy breast reconstruction has risen from 19.4% in 2015 to 53.4% in 2018. Furthermore, the American Society of Plastic Surgeons reports that the number of breast reconstruction procedures performed has increased from 78,882 in 2000 to 137,808 in 2020, propelling market growth.
- Rise in number of breast cancer patients
The number of breast cancer patients worldwide has increased. Breast cancer will be diagnosed in approximately 2.3 million women worldwide by 2020, according to the WHO. Furthermore, between 2015 and 2020, more than 7.8 million new cases of breast cancer were diagnosed, according to a similar source. Furthermore, according to Cancer Research UK, approximately 55,900 new cases of breast cancer are diagnosed in the United Kingdom each year. Furthermore, breast cancer is the most common type of cancer in the United Kingdom, according to a similar source. As the number of people diagnosed with breast cancer rises, so the demand for breast reconstruction, propelling market growth during the forecast period. Similarly, according to Breast Cancer Now, one in every seven women in the United Kingdom will be diagnosed with breast cancer. As a result of the increased number of people suffering, the market will grow.
Opportunities
- Technological innovations
One of the innovations expected to influence breast reconstruction markets is 3D printing, which is used to create soft absorbable shells with silicon filling to integrate with the specific medical needs of patients. The increasing use of silicone and saline breast implants, ADMs, and tissue expanders is expected to be a major trend in breast reconstruction in the coming years.
Restraints/Challenges
- High cost of surgical expenses
The breast reconstruction market's growth has been stifled by high surgical costs and difficulties, such as adverse effects of surgical operations, changes in nipple and breast sensation, scar development, and, in some cases, rupture with deflation of saline-filled implants associated with breast reconstructions. These problems are related to Acellular Dermal Matrices (ADMs), as hematoma, skin necrosis, and seroma are the most commonly reported complications after ADM breast reconstruction procedures.
This breast reconstruction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the breast reconstruction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2020, AbbVie Inc. eventually acquired Allergan, combining their product portfolios. This acquisition aided AbbVie Inc. in expanding its market and demand for its product in the future by combining both companies' product portfolios, thereby strengthening their business.
- In 2019, Johnson & Johnson Services, Inc.'s brand Mentor received FDA approval for the Memory Shape device under Premarket Approval (PMA) Application. This has aided the company's portfolio expansion in the breast reconstruction implant market.
North America Breast Reconstruction Market Scope
The breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Breast Implants
- Silicone Implants
- Saline Implants
- Tissue Expanders
- Acellular Dermal Matrix
Type
- Unilateral
- Bilateral
Shape
- Round Implants
- Anatomical Implants
Technology
- Inframammary
- Peri-Areolar
- Trans-Axillary
- Transumbilical
Placement
- Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
Procedure
- Immediate Procedures
- Delayed Procedures
- Revision Procedures
End User
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Others
Competitive Landscape and North America Breast Reconstruction Market Share Analysis
The breast reconstruction market is analyzed and market size insights and trends are provided by country, product, type, shape, technology, placement, procedure and end user as referenced above.
The countries covered in the breast reconstruction market report are U.S., Canada and Mexico in North America.
U.S. dominates the North America breast reconstruction market because of the rising prevalence of breast cancer and the key market players' strong local presence.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The breast reconstruction market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast reconstruction market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast reconstruction market. The data is available for historic period 2011-2021.
Competitive Landscape and North America Breast Reconstruction Market Share Analysis
The breast reconstruction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to breast reconstruction market.
Some of the major players operating in the breast reconstruction market are:
- POLYTECH Health & Aesthetics GmbH (Germany)
- CEREPLAS (France)
- Guangzhou Wanhe Plastic Material Co., Ltd (China)
- AbbVie Inc. (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- GC Aesthetics (U.K.)
- Laboratories Arion (France)
- Sientra Inc. (California)
- HANSBIOMED CO. LTD (South Korea)
- Sientra, Inc. (U.S.)
- Deal Implant Incorporated (U.S.)
- Integra LifeSciences (U.S.)
- PMT Corporation (U.S.)
- RTI Surgical (U.S.)
- Establishment Labs S.A. (U.S.)
- Silimed (Brazil)
SKU-